A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study. Solriamfetol is a nonstimulant drug that is approved for sleepiness caused by narcolepsy (sudden sleep attacks) and obstructive sleep apnea (marked by breathing lapses during… read on > read on >
Americans are losing sleep over worries about money, a new survey reveals. The American Academy of Sleep Medicine (AASM) polled about 2,000 U.S. adults, finding that 69% reported lost sleep due to concerns about job security and 75% were kept up with thoughts about whether the United States would enter a recession. “Persistent, anxious thoughts… read on > read on >
The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders. Compounded products are not evaluated by the FDA for safety and effectiveness. They’re also not regulated like approved drugs, so they present a greater risk. “Although compounded drugs can serve an… read on > read on >
Cigarette makers are using synthetic menthol substitutes in what appears to be an effort to skirt a looming federal menthol ban, researchers say. The menthol flavor appeals to younger and newer smokers, according to investigators at Duke Health in Durham, N.C., and Yale University in New Haven, Conn. These new “non-menthol” cigarettes are being introduced… read on > read on >
Toilet bowls reveal much about the health of a community, alerting scientists to coming outbreaks of flu and other seasonal viruses, researchers say. “Just one flush can hold a lot of information,” said Kristine Du, co-author of a new Canadian study. “Wastewater surveillance equips public health experts, clinicians, policymakers and the public with community-based, objective… read on > read on >
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis, vitiligo (white skin patches), vasculitis (inflammation of blood vessels), Crohn’s disease, ulcerative colitis, rheumatoid arthritis, adult-onset Still’s disease (painful skin rash), Sjogren’s syndrome (autoimmune disease), ankylosing spondylitis (spinal arthritis) and… read on > read on >
For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them. Dubbed XEN1101, the new drug reduced the frequency of seizures by more than 50%, or even eliminated them, in some patients with focal epilepsy who did not respond to… read on > read on >
It has long been believed that the 1918 flu pandemic disproportionately affected healthy young adults, but a study of human remains tells a different story. Together, Canadian and American researchers found that preexisting medical conditions like asthma and lower income increased the likelihood of death, just as in other pandemics, including COVID-19. “Our circumstances —… read on > read on >
A majority of people who have a minimally invasive heart valve replacement procedure are not getting the recommended cardiac rehab after their surgeries, researchers say. A new study finds that just under 31% of patients who have transcatheter aortic valve replacement (TAVR) are receiving this service within 90 days of the procedure. This could be… read on > read on >
As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution. The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles back on as soon as the medication stops. There are also financial and… read on > read on >
